TY - JOUR
T1 - 5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-κB activation
AU - Islam, Shamima
AU - Hassan, Ferdaus
AU - Tumurkhuu, Gantsetseg
AU - Ito, Hiroyasu
AU - Koide, Naoki
AU - Mori, Isamu
AU - Yoshida, Tomoaki
AU - Yokochi, Takashi
PY - 2007/2
Y1 - 2007/2
N2 - The effect of 5-fluorouracil (5-FU) on the production of nitric oxide (NO) in macrophages was examined by using lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. 5-FU at non-toxic concentrations significantly inhibited NO production in LPS-stimulated RAW 264.7 cells. The inhibition by 5-FU was mediated by attenuated expression of an inducible NO synthase protein and mRNA. 5-FU inhibited the activation of nuclear factor (NF)-κB and the subsequent nuclear translocation. Furthermore, 5-FU inhibited the phosphorylation of Akt, an upstream molecule of NF-κB signaling. 5-FU did not affect a series of mitogen-activated protein kinases. Therefore, 5-FU was suggested to inhibit the LPS-induced NO production in activated macrophages through preventing Akt-dependent NF-κB activation.
AB - The effect of 5-fluorouracil (5-FU) on the production of nitric oxide (NO) in macrophages was examined by using lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. 5-FU at non-toxic concentrations significantly inhibited NO production in LPS-stimulated RAW 264.7 cells. The inhibition by 5-FU was mediated by attenuated expression of an inducible NO synthase protein and mRNA. 5-FU inhibited the activation of nuclear factor (NF)-κB and the subsequent nuclear translocation. Furthermore, 5-FU inhibited the phosphorylation of Akt, an upstream molecule of NF-κB signaling. 5-FU did not affect a series of mitogen-activated protein kinases. Therefore, 5-FU was suggested to inhibit the LPS-induced NO production in activated macrophages through preventing Akt-dependent NF-κB activation.
UR - http://www.scopus.com/inward/record.url?scp=33845371107&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845371107&partnerID=8YFLogxK
U2 - 10.1007/s00280-006-0261-2
DO - 10.1007/s00280-006-0261-2
M3 - Article
C2 - 16724238
AN - SCOPUS:33845371107
VL - 59
SP - 227
EP - 233
JO - Cancer Chemotherapy and Pharmacology
JF - Cancer Chemotherapy and Pharmacology
SN - 0344-5704
IS - 2
ER -